Unseen 13

13% of patients (1 in 8) with non-small cell lung cancer (NSCLC) have the KRAS G12C mutation, yet too many go undetected1,2

KRAS, Kirsten rat sarcoma.

References: 1. Biernacka A, et al. Cancer Genet. 2016;209:195-198. 2. Gutierrez ME, et al. Clin Lung Cancer. 2017;18:651-659.